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column was washed with the same buffer supplemented with 10 mM imidazole, and the protein was eluted with 200 mM imidazole. Fractions containing the protein were pooled, concentrated to below 10 mL, and further purified by size exclusion chromatography in 50 mM Tris (pH 8.0), 150 mM KCl, 5% glycerol, and 1 mM dithiothreitol (DTT) using a HiLoad 26/60 Superdex column (GE Healthcare Life Sciences) to yield pure protein (over 95% as indicated by SDS-PAGE analysis). The protein was concentrated to 7-12 mg/mL. Protein concentrations were determined from the absorbance at 280 nm using the calculated extinction coefficient ε = 50,240 Enzyme Activity Assays. The Fluor-de-Lys tetrapeptide assay substrate Ac-Arg-HisLys(Ac)-Lys(Ac)-aminomethylcoumarin (BML-KI178-0005, Enzo Life Sciences) was used to measure the catalytic activities of HDAC8 mutants. 3 Deacetylation of the substrate by HDAC8 is followed by the cleavage of the amide bond linking the C-terminal 7-amino-4-methylcoumarin (AMC) to the peptide backbone by a protease developer, resulting in a fluorescence shift.
Activity assays were run at 25°C in assay buffer (25 mM Tris (pH 8.2), 137 mM NaCl, 2.7 mM KCl, and 1 mM MgCl) and contained 150 µM tetrapeptide substrate with the following enzyme concentrations: 0.5 µM (wild-type), 0.75 µM (H334R), 1.5 µM (A188T, I243N) or 3 µM (T311M, Heat inactivation studies were performed using a 10 µM enzyme stock solutions at 37°C
for 15, 30, or 60 min after which the enzymes were diluted to the desired concentration for S4 activity assay. Activity assays after heat inactivation were performed at 25°C under the same conditions as described above. All assays were run in triplicate. HDAC8 was cocrystallized with inhibitor SAHA using a precipitant solution of 100 mM BisTris (pH 6.5), 18% PEG 8,000, and 4 mM TCEP. T311M HDAC8 was cocrystallized with inhibitor TSA using a precipitant solution of 100 mM bicine (pH 8. Data collection statistics are presented in Table S2 . Data were indexed, integrated and scaled using HKL2000. Structural Biology Laboratory, http://www.ysbl.york.ac.uk/YSBLPrograms/). 9 The corrected solution was used to successfully complete refinement.
Certain segments in each structure (the N-terminus, the C-terminus, and/or a portion of the L2 loop) appeared to be disordered and were accordingly excluded from each final model as follows: C153F HDAC8, M1-S13 (monomers A and B), H385-H389 (monomer A), I378-H389 Complete refinement statistics are recorded in Table S2. S8 Table S1 . Primers used to generate HDAC8 mutants Table S3 . Activation data shown in Figure 7 Activity ( (which presumably must be protonated to accomodate this interaction). In C153F HDAC8, however, the amide group of SAHA is flipped so that the NH benzamide group interacts with Asp101 through a bridging hydrogen bonded water molecule. Water molecules observed in the mutant enzyme active site appear as red spheres. In the wildtype HDAC8-SAHA complex, the benzamide carbonyl group of SAHA forms a hydrogen with Asp101 (which presumably must be protonated to accomodate this interaction). In I243N HDAC8, however, the amide group of SAHA is flipped so that the NH benzamide group is directed toward Asp101; however, the N---O separation is too long (> 4 Å ) for a hydrogen bond interaction. Additionally, the benzamide carbonyl group of SAHA group interacts with a network of hydrogen bonded solvent molecules that in turn interact with His180, the backbone NH group inhibitor is a hydroxamate group that targets metal coordination interactions with the active site zinc ion, which is a standard design motif for HDAC8 inhibitors.
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